Drug intelligence / Profile preview

Tongluo Jiunao

Development stage
Phase 2
Lead developer
Inner Mongolia Kangyuan Pharmaceutical
Administration
Intravenous
01

Overview

Tongluo Jiunao is a Traditional Chinese Medicine (TCM) injection developed by Inner Mongolia Kangyuan Pharmaceutical for the treatment of acute cerebral infarction (ischemic stroke). It is a standardized herbal preparation primarily composed of extracts from *Panax notoginseng* (Sanchi) and *Gardenia jasminoides* (Zhizi), with key active constituents including ginsenoside Rg1, ginsenoside Rb1, and geniposide. The drug is designed to address the TCM syndrome of 'wind-fire disturbing upward and blood stasis blocking collaterals.' Mechanistically, Tongluo Jiunao provides neuroprotection by reducing cerebral edema, inhibiting inflammatory cytokine release, and preventing neuronal apoptosis in the ischemic penumbra. It has undergone Phase II clinical evaluation in China to assess its safety and efficacy in patients during the acute phase of stroke.

Brand names
Tongluo Jiunao
Other names
Tongluo Jiunao Injection
02

Targets

CASP3 (Caspase-3)IL1B (Interleukin-1 beta)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Tongluo Jiunao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tongluo Jiunao.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call